Flavia Cerrato

Prof. Dr. Flavia Cerrato

University of Campania "Luigi Vanvitelli", Caserta, Campania, Italy
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2020 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
MAria Vittoria CubellisMAria Vittoria Cubellis
MAria Vittoria Cubellis
LPLaura Pignata
Laura Pignata
AVAnkit Verma
Ankit Verma
ASAngela Sparago
Angela Sparago
RPRosita Del Prete
Rosita Del Prete
ARAndrea Riccio
Andrea Riccio
Background: PADI6 is a component of the subcortical maternal complex, a group of proteins that is abundantly expressed in the oocyte cytoplasm, but is required for the correct development of early embryo. Maternal-effect variants of the subcortical maternal complex proteins are associated with heterogeneous diseases, including female infertility, hydatidiform mole, and imprinting disorders with multi-locus imprinting disturbance. While the involvement ofPADI6in infertility is well demonstrated, its role in imprinting disorders is less well established.Results: We have identified by whole-exome sequencing analysis four cases of Beckwith-Wiedemann syndrome with multi-locus imprinting disturbance whose mothers are carriers ofPADI6variants. In silico analysis indicates that these variants result in loss of function, and segregation analysis suggests they act as either recessive or dominant-negative maternal-effect mutations. Genome-wide methylation analysis revealed heterogeneous and extensively altered methylation profiles of imprinted loci in the patients, including two affected sisters, but not in their healthy siblings.Conclusion: Our results firmly establish the role ofPADI6in imprinting disorders. We report loss-of-function maternal-effect variants ofPADI6that are associated with heterogeneous multi-locus imprinting disturbances in the progeny. The rare finding of two siblings affected by Beckwith-Wiedemann syndrome suggests that in some cases, familial recurrence risk of these variants may be high. However, the heterogeneous phenotypes of the other pedigrees suggest that altered oocytePADI6function results in stochastic maintenance of methylation imprinting with unpredictable consequences on early embryo health.

12 January 2019 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
FVFederica Maria Valente
Federica Maria Valente
ASAngela Sparago
Angela Sparago
AFAndrea Freschi
Andrea Freschi
KHKatherine Hill-Harfe
Katherine Hill-Harfe
SMSaskia M. Maas
Saskia M. Maas
FCFlavia Cerrato
Flavia Cerrato
Purpose Beckwith–Wiedemann syndrome (BWS) is a developmental disorder caused by dysregulation of the imprinted gene cluster of chromosome 11p15.5 and often associated with loss of methylation (LOM) of the imprinting center 2 (IC2) located in KCNQ1 intron 10. To unravel the etiological mechanisms underlying these epimutations, we searched for genetic variants associated with IC2 LOM. Methods We looked for cases showing the clinical features of both BWS and long QT syndrome (LQTS), which is often associated with KCNQ1 variants. Pathogenic variants were identified by genomic analysis and targeted sequencing. Functional experiments were performed to link these pathogenic variants to the imprinting defect. Results We found three rare cases in which complete IC2 LOM is associated with maternal transmission of KCNQ1 variants, two of which were demonstrated to affect KCNQ1 transcription upstream of IC2. As a consequence of KCNQ1 haploinsufficiency, these variants also cause LQTS on both maternal and paternal transmission. Conclusion These results are consistent with the hypothesis that, similar to what has been demonstrated in mouse, lack of transcription across IC2 results in failure of methylation establishment in the female germline and BWS later in development, and also suggest a new link between LQTS and BWS that is important for genetic counseling.

26 March 2020 in Genes
Verified
Journal Article
Open access
PDF file
FCFlavia Cerrato
Flavia Cerrato
ASAngela Sparago
Angela Sparago
FAFrancesca Ariani
Francesca Ariani
FBFulvia Brugnoletti
Fulvia Brugnoletti
LCLUCIANO CALZARI
LUCIANO CALZARI
ARAndrea Riccio
Andrea Riccio
DNA methylation in the human genome is largely programmed and shaped by transcription factor binding and interaction between DNA methyltransferases and histone marks during gamete and embryo development. Normal methylation profiles can be modified at single or multiple loci, more frequently as consequences of genetic variants acting in cis or in trans, or in some cases stochastically or through interaction with environmental factors. For many developmental disorders, specific methylation patterns or signatures can be detected in blood DNA. The recent use of high-throughput assays investigating the whole genome has largely increased the number of diseases for which DNA methylation analysis provides information for their diagnosis. Here, we review the methylation abnormalities that have been associated with mono/oligogenic diseases, their relationship with genotype and phenotype and relevance for diagnosis, as well as the limitations in their use and interpretation of results.

1 February 2024 in Genes & Development
Verified
Journal Article
Open access
PDF file
CGCarlo Giaccari
Carlo Giaccari
FCFrancesco Cecere
Francesco Cecere
LALucia Argenziano
Lucia Argenziano
APAngela Pagano
Angela Pagano
AGAntonio Galvao
Antonio Galvao
ARAndrea Riccio
Andrea Riccio
Maternal inactivation of genes encoding components of the subcortical maternal complex (SCMC) and its associated member, PADI6, generally results in early embryo lethality. In humans, SCMC gene variants were found in the healthy mothers of children affected by multilocus imprinting disturbances (MLID). However, how the SCMC controls the DNA methylation required to regulate imprinting remains poorly defined. We generated a mouse line carrying aPadi6missense variant that was identified in a family with Beckwith–Wiedemann syndrome and MLID. If homozygous in female mice, this variant resulted in interruption of embryo development at the two-cell stage. Single-cell multiomic analyses demonstrated defective maturation ofPadi6mutant oocytes and incomplete DNA demethylation, down-regulation of zygotic genome activation (ZGA) genes, up-regulation of maternal decay genes, and developmental delay in two-cell embryos developing fromPadi6mutant oocytes but little effect on genomic imprinting. Western blotting and immunofluorescence analyses showed reduced levels of UHRF1 in oocytes and abnormal localization of DNMT1 and UHRF1 in both oocytes and zygotes. Treatment with 5-azacytidine reverted DNA hypermethylation but did not rescue the developmental arrest of mutant embryos. Taken together, this study demonstrates that PADI6 controls both nuclear and cytoplasmic oocyte processes that are necessary for preimplantation epigenetic reprogramming and ZGA.

11 December 2019 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
ASAngela Sparago
Angela Sparago
AVAnkit Verma
Ankit Verma
MPMaria Grazia Patricelli
Maria Grazia Patricelli
LPLaura Pignata
Laura Pignata
SRSilvia Russo
Silvia Russo
ARAndrea Riccio
Andrea Riccio
Background: A subset of individuals affected by imprinting disorders displays multi-locus imprinting disturbances (MLID). MLID has been associated with maternal-effect variants that alter the maintenance of methylation at germline-derived differentially methylated regions (gDMRs) in early embryogenesis. Pedigrees of individuals with MLID also include siblings with healthy phenotype. However, it is unknown if these healthy individuals have MLID themselves or if their methylation patterns differ from those associated with imprinting disorders, and in general, if MLID affects the clinical phenotype. Methods: We have investigated gDMR methylation by locus-specific and whole-genome analyses in a family with multiple pregnancy losses, a child with Beckwith-Wiedemann syndrome (BWS) and a further child with no clinical diagnosis of imprinting disorder or other pathologies. Results: We detected MLID with different methylation profiles in the BWS-affected and healthy siblings. Whole-exome sequencing demonstrated the presence of novel loss-of-function variants of NLRP5 in compound heterozygosity in the mother. The methylation profiles of the two siblings were compared with those of other cases with MLID and control groups by principal component analysis and unsupervised hierarchical clustering, but while their patterns were clearly separated from those of controls, we were unable to cluster those associated with specific clinical phenotypes among the MLID cases. Conclusion: The identification of two novel maternal-effect variants of NLRP5 associated with poly-abortivity and MLID adds further evidence to the role of this gene in the maintenance of genomic imprinting in early embryos. Furthermore, our results demonstrate that within these pedigrees, MLID can also be present in the progeny with healthy phenotype, indicating that some sort of compensation occurs between altered imprinted loci in these individuals. The analysis of larger cohorts of patients with MLID is needed to formulate more accurate epigenotype-phenotype correlations.

12 September 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SHStella K. Hur
Stella K. Hur
AFAndrea Freschi
Andrea Freschi
FIFolami Ideraabdullah
Folami Ideraabdullah
JTJoanne L. Thorvaldsen
Joanne L. Thorvaldsen
LLLacey J. Luense
Lacey J. Luense
MBMarisa Bartolomei
Marisa Bartolomei
Significance: Genomic imprinting is essential for mammalian development. Curiously, elements that regulate genomic imprinting, the imprinting control regions (ICRs), often diverge across species. To understand whether the diverged ICR sequence plays a species-specific role at the H19/insulin-like growth factor 2 ( Igf2 ) imprinted locus, we generated a mouse in which the human ICR (hIC1) sequence replaced the endogenous mouse ICR. We show that the imprinting mechanism has partially diverged between mouse and human, depending on the parental origin of the hIC1 in mouse. We also suggest that our mouse model is optimal for studying the imprinting disorders Beckwith–Wiedemann syndrome when hIC1 is maternally transmitted, and Silver–Russell syndrome when hIC1 is paternally transmitted.